Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
J Med Case Rep ; 16(1): 119, 2022 Mar 22.
Article in English | MEDLINE | ID: covidwho-1753123

ABSTRACT

PURPOSE: During the severe acute respiratory syndrome coronavirus 2 pandemic, several patient groups are at particular risk. Mortality is higher among cancer patients and may be increased further by thromboembolic events, which are more common in coronavirus 2019 patients according to recent publications. We discuss the association of gynecologic malignancies, Severe acute respiratory syndrome coronavirus 2, and thromboembolism by reporting a case study and summarizing available literature. CASE REPORT: A 71-year-old Caucasian patient with ovarian cancer receiving first-line chemotherapy was diagnosed with deep vein thrombosis and pulmonary embolism. Routine screening revealed infection with severe acute respiratory syndrome coronavirus 2 in absence of specific symptoms. After uneventful recovery, oncologic treatment could be continued a few weeks later. METHODS: We performed a systematic review of the literature on PubMed following Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. The search included articles ahead of print, published between 1 December 2019 and 1 June 2020. Cross-searches were conducted on all relevant articles. RESULTS: We identified five articles meeting the defined criteria, including two retrospective studies, a review, a position paper, as well as a letter to the editor. CONCLUSION: Cancer patients infected with severe acute respiratory syndrome coronavirus 2 have a relatively poor outcome, which may partially be due to a higher rate of thromboembolic events. Thromboprophylaxis is recommended, and scoring systems are helpful in early detection. In cancer patients with severe acute respiratory syndrome coronavirus 2, individual risk for thromboembolic events should be taken into account when considering interruption versus continuation of antitumoral therapy. However, further data and studies are required.


Subject(s)
COVID-19 , Genital Neoplasms, Female , Venous Thromboembolism , Aged , Anticoagulants/therapeutic use , COVID-19/complications , Female , Genital Neoplasms, Female/complications , Humans , Retrospective Studies
2.
HMD Praxis der Wirtschaftsinformatik ; 2021.
Article in English | PMC | ID: covidwho-1339405

ABSTRACT

Krisen erfordern flexibles Handeln und schnelle Anpassungen sowohl von Menschen als auch von öffentlichen Institutionen. Die öffentliche Hand und insbesondere die deutschen Gesundheitsbehörden sind während der Covid-19-Pandemie, beginnend im März 2020, massiv herausgefordert. Die Bewältigung des teilweise exponentiell wachsenden Prozessvolumens durch kurzfristige Infektionsereignisse muss in kürzester Zeit fachgerecht erfolgen und unterliegt einer permanenten Reaktion und Anpassung an sich ändernde Rahmenbedingungen. Bestehende Strukturen und ineffiziente Prozesse erschweren diese notwendige Skalierung der Bearbeitung zunehmend. In diesem Beitrag werden mittels Aktionsforschung Ansätze für eine beschleunigte und flexible Entwicklung von Robotic Process Automation (RPA)-Lösungen zur Automatisierung bestehender Verwaltungsprozesse innerhalb einer betroffenen Gesundheitsbehörde in Deutschland untersucht. Als Ergebnis wurden Ansätze für eine schnellere und weniger komplexe Entwicklung von RPA-Lösungen in einer sehr schnell skalierenden und gleichzeitig stark heterogenen IT-Systemlandschaft erarbeitet und bewertet.

SELECTION OF CITATIONS
SEARCH DETAIL